ArticleFrontiers in immunology2024

Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission.

Xiaojuan Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.